Skip to content

Author

M. Ersbøll

We have 2 of 99 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial.

This randomized study of SGLT2i in pre-capillary PH showed that 12 weeks of dapagliflozin did not significantly improve exercise capacity, hemodynamics, or functional status compared to placebo.

M. Ersbøll, J. Kjaergaard, K. Waidtløw et al. · 1 citation
Open access Aug 2026

Ambulatory low cardiac output state in heart failure: characteristics and outcomes

Abstract Introduction Ambulatory low cardiac output state (LCOS) is a known but poorly described heart failure (HF) phenotype. We aimed to investigate the prevalence, clinical markers, and prognostic importance of ambulatory LCOS. Methods Consecutive ambulatory patients with HF and reduced left ventricular ejection fra...

B. Hansen, T. Deis, Cecilie Müller Ralsted et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.